MedTech News Briefs | September 11th, 2023

Tuesday September 5th

Abbott agrees to acquire Bigfoot Biomedical. The acquisition will combine two leaders in different aspects of diabetes care. The acquisition is expected to close in Q3 of 2023.
New knee replacement system, TriVerse, debuted. The system developed by Exactech is a primary knee system that looks to address the increasing demand for knee replacements.
DNA extraction workstation launched in APAC and Middle East. Developed by Yourgene, MagBench DNA extraction solution is an automated system the reduces human error by reducing manual intervention. The aim of the device is to change non-invasive prenatal testing.

Wednesday September 6th

Analysis Technique to improve cancer diagnosis and treatment. Developed by the University of Wisconsin-Madison, the technique uses machine learning and DNA floating in the bloodstream. The technique is also compatible with liquid biopsy testing leading to a much less invasive biopsy than tissue biopsy.
Boston Scientific receives FDA approval for next-generation Watchman FLX. The device is the company’s latest left atrial appendage closure device. The new generation improves performance and safety.
Cancer diagnostics company Ibex Medical Analytics receives $55 million in funds. The company is working develop an AI workflow and decision support tool to help with biopsies. The platform provides broad tissue coverage for cancer diagnosis.

Thursday September 7th

UK becomes member of Horizon Europe programme. By joining this program, the UK will be able to work in cooperation with other EU countries on research projects and technologies from health to AI.
Multi-device connective, wireless handheld ultrasound device launched. Launched by Mindray, the device is the first in the industry of handheld ultrasound devices that can connect with a mobile device or the TE X ultrasound system. The device allows for better utility and accessibility.
Laborie Medical Technologies to enter an agreement to aquire Urotronic in $600m deal. The deal would strengthen Laborie’s urology portfolio.

Friday September 8th

British Healthcare Trades Association and the United Kingdom government have announced a partnership to foster growth and collaboration for healthcare companies in the UK.
Bacteria capable of detecting the presence of tumor DNA developed by scientists at University of California San Diego with the help of colleagues from Australia.
3D printed hydrogel dressings developed for burn injuries. The dressings will speed up and improve healing using bioactive formulations.

Sources

ThinkMedTek